Skip to content
Why Dr. Jay Bhattacharya Is the Right Choice to Reform the NIH
Justin Perry /

Why Dr. Jay Bhattacharya Is the Right Choice to Reform the NIH

Known for criticizing COVID mandates, he has shown courage in taking on the scientific establishment.
House Freedom Caucus COVID Roundtable
Dr. Jay Bhattacharya speaks during a roundtable discussion with members of the House Freedom Caucus on the COVID-19 pandemic at the Heritage Foundation on Thursday, November 10, 2022. (Tom Williams/CQ-Roll Call, Inc via Getty Images)

The discovery of cures for cancer are rare, but in the last 20 years, we have seen remarkable progress, highlighted by the discovery and development of immune checkpoint blockade therapies. Then, in 2022, the unimaginable happened. Dr. Andrea Cercek, a medical oncologist from Memorial Sloan Kettering Cancer Center, and colleagues reported that the use of immune checkpoint blockade cured 12 patients with a specific type of rectal cancer.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Justin S. A. Perry is an immunologist and cancer biologist. He is an Assistant Member at Memorial Sloan Kettering Cancer Center and an Assistant Professor at Weill Cornell Medicine. The views and opinions expressed here do not necessarily reflect those of his employer.

More on the Trump Transition

Loading